Impact of COVID-19 on Drug Development in Rare Disease and Oncology
The full effect of the COVID-19 pandemic, particularly on the search for rare disease and oncology treatments, is still uncertain. What we do know is that patients diagnosed with these conditions simply cannot afford delays. With a patient-centric approach and guided by the best minds in the industry, Parexel has a broad perspective to help sponsors, regulators, and patients during this difficult time. We have learned a great deal over the past few months about trial conduct, patient recruitment, risk mitigation, the pace of regulatory approvals, and how patients are faring. And now we want to share this information with you.